CLA-positive cells can use both VLA-4/VCAM-1 and LFA-1/ICAM-1 for extravasation on skin surfaces (48), which could account the enrichment of T cells expressing this receptor in the lesion of cutaneous leishmaniasis patients (18, 49). The gene discussed is VCAM1; the disease is cutaneous leishmaniasis.